• Menu
  • Skip to main content
  • Skip to secondary navigation
  • Skip to primary sidebar
  • Skip to footer

Before Header

  • About
  • Search
  • Resources
  • Privacy
  • Contact
 

Amaxx Workers Comp Blog

Reduce Workers Compensation Costs By 20-50%

Header Right

  • Home
  • Books
    • Big Book
    • Mini Book
  • Training
    • WC Mastery Membership
    • Course Curriculum
    • Certified Master of Workers’ Compensation
    • Certified Master of WC – Best in Class
  • Coaching
    • CompElite Strategic Coaching for Employers
    • BrokerElite Coaching for WC Business Growth
  • IMR Software
    • IMR Comprehensive
    • IMR Metrics Suite
  • Blog
  • WC Help

Mobile Menu

  • Home
  • Books
    • Big Book
    • Mini Book
  • Training
    • WC Mastery Membership
    • Course Curriculum
    • Certified Master of Workers’ Compensation
    • Certified Master of WC – Best in Class
  • Coaching
    • CompElite Strategic Coaching for Employers
    • BrokerElite Coaching for WC Business Growth
  • IMR Software
    • IMR Comprehensive
    • IMR Metrics Suite
  • Blog
  • WC Help
  • About
  • Search
  • Resources
  • Privacy
  • Contact
You are here: Home / Workers Comp News / NAMSAP Endorses Surgeon General’s “Turn the Tide Rx” Campaign

NAMSAP Endorses Surgeon General’s “Turn the Tide Rx” Campaign

September 21, 2016 By //  by Senior Editor Leave a Comment

namsap-image NAMSAP says workers’ compensation MSAs are still allocating for high doses of long-acting opioids, against evidence-based guidelines.

 

Business Wire version: NAMSAP Endorses Surgeon General’s “Turn the Tide Rx” Campaign

 

Elmhurst, Illinois (September 12, 2016) — The National Alliance of Medicare Set-Aside Professionals has endorsed the U.S. Surgeon General’s “Turn the Tide Rx” campaign to end the opioid epidemic. The campaign’s goals are to educate prescribers and the public about opioids, change the cultural perception of addiction, and mobilize health care professionals to improve prescribing practices.

 

NAMSAP wants physicians to adhere to evidence-based guidelines pertaining to opioids. The organization also would like to see the Centers of Medicare and Medicaid Services follow its own Part D guidelines when reviewing and approving Workers’ Compensation Medicare Set-Asides (WCMSAs).

 

The Turn the Tide Rx website promotes guidelines that encourage physicians to prescribe the lowest effective dose of immediate-release opioids only for acute pain and only for short durations, usually three days or less and rarely more than seven days. It says: “Higher dosages of opioids are associated with higher risk of overdose and death, but higher dosages have not been shown to reduce pain over the long term. Extra precautions should be used when increasing to greater than 50 morphine milligram equivalents (MME) per day.”

 

“Opioid guidelines have been around for years, but there are situations where the treating physician is writing for high doses of long-acting opioids. In those cases, CMS requires that the WCMSA allocate for these opioids for the patient’s life expectancy,” says NAMSAP President Gary Patureau. “Our members often see more than 50 MME per day on workers’ compensation and general liability claims for people with chronic pain who have life expectancies of 20 to 40 years or more. Essentially, CMS is condoning the dangerous and inappropriate use of opioids.”

 

The campaign’s website also warns, “It is is especially dangerous to combine opioids with alcohol or sedatives, like benzodiazepines (e.g., lorazepam/Ativan, alprazolam/Xanax, diazepam/Valium).” Patureau says opioids and benzodiazepines are frequently prescribed together and allocated on WCMSAs.

 

“Post settlement, many Medicare beneficiaries do not reach their life expectancies,” he notes. “What is causing their deaths? No one is tracking this, but we suspect overdose is responsible for some.”

 

For more information on the Surgeon General’s campaign and to download educational materials, please see www.turnthetiderx.org. The Turn the Tide Rx endorsement is the latest of several NAMSAP initiatives to reduce opioid use in MSAs. The organization has conducted webinars on the topic and proposed evidence-based limits on opioids in MSAs in March.

 

 

About NAMSAP

 

Headquartered in Illinois, NAMSAP is the only non-profit association exclusively addressing the issues and challenges of the Medicare Secondary Statutes and its impact on workers’ compensation and liability settlements. Its members are comprised of MSA providers, insurance carriers, and third-party administrators. Contact NAMSAP at 855-677-2776 or via www.namsap.org.

 

# # #

 

 

Media Contact: Brian S. Bailey, NAMSAP Executive Director, (855) 677-2776; Brian@NAMSAP.org
Web: www.NAMSAP.org

Filed Under: Workers Comp News

Related Articles

Paradigm Expands Surgical Implant Review into Full-Scope Cost Management Solution

Paradigm Expands Surgical Implant Review into Full-Scope Cost Management Solution

WCRI 2024 Preview: What I’m Looking Forward to Seeing

WCRI 2024 Preview: What I’m Looking Forward to Seeing

RIMS Awards The Risk Manager Of The Year Honor To Kite Realty Group’s Theresa Severson

RIMS Awards The Risk Manager Of The Year Honor To Kite Realty Group’s Theresa Severson

The National Medicare Secondary Payer Network Installs New Officers And Directors

The National Medicare Secondary Payer Network Installs New Officers And Directors

Paradigm Announces Acquisition of Welvie

Paradigm Announces Acquisition of Welvie

Paradigm Announces Clinical Solutions Leadership Promotions

Paradigm Announces Clinical Solutions Leadership Promotions

Paradigm Receives 2022 Great Place to Work Certification

Paradigm Receives 2022 Great Place to Work Certification

An Advocacy Approach in Claims Handling

An Advocacy Approach in Claims Handling

WCRI Pulls Out All the Stops for Its Annual Conference

WCRI Pulls Out All the Stops for Its Annual Conference

Paradigm Appoints Elizabeth Ulloa Lowry as Senior Vice President of Case Management

Paradigm Appoints Elizabeth Ulloa Lowry as Senior Vice President of Case Management

The Three Strategies to Stay Safe During an Active Shooter Situation

The Three Strategies to Stay Safe During an Active Shooter Situation

The COVID-19 Impact: Exploring the Long-Term Effects and Management of COVID-19 Cases

The COVID-19 Impact: Exploring the Long-Term Effects and Management of COVID-19 Cases

Free Download

The 5 Cs For Taking A Bulletproof Injured Worker Recorded Statement - FREE Download Click Here Now!

Train to Succeed

BECOME CERTIFIED IN WORKERS’ COMPENSATION

Proven Course Catalog & WC Toolbox Give You The Power To Achieve Lower Costs and Better Injured Worker Outcomes

VISIT WORKERS' COMP TRAINING CENTER

Previous Post: « DWC Will Enforce Lien Claimants’ Usage of Uniform Assigned Name
Next Post: Nebraska Employer Cited for Putting Workers in Danger »

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

FREE DOWNLOAD

The 5 Cs For Taking A Bulletproof Injured Worker Recorded Statement - FREE Download Click Here Now!

Our Sponsors

Catastrophic and Risk Solutions, Case Management Solutions, and Specialty Networks
 

WC Cost-Driver Metrics Suite

Blog Categories

Search Our Archive

Subscribe to Our FREE Newsletter

Return-to-Work Essentials

Footer

Search Our Archive

Search our continually growing archive of over 5,000 articles about Workers' Comp issues.

Quiclinks

  • Calculators
  • Terms & Abbreviations
  • Glossary of WC Premium Terms
  • WC Resources
  • Best Practices
  • Industries
  • Return-to-Work Essentials

RSS Recent Blog Posts

  • Building Partnerships, Not Transactions: The Secret to Better Claims Outcomes
  • Building Your Workers’ Comp Dream Team
  • Your Workers’ Comp Oasis: Why Vision Comes Before Action
SUBSCRIBE TO OUR FEE NEWSLETTER
Let Us Help You Stomp Down the High Cost of Workers' Comp!
Top of Page ↑
  • Home
  • Training Center
  • Search
  • Membership
  • Products
  • Blog
  • About
  • Contact
  • Subscribe
  • Login
Copyright © 2025 Amaxx, LLC. All Rights Reserved. · Privacy Policy / Legal Notice